Drug class in one race
NKCC2 drugs for Heart Failure
3 tracked NKCC2 drugs in the Heart Failure race. The class explanation lives on the NKCC2 page; the full indication pipeline across every mechanism is on the Heart Failure page.
3 approved / phase 4
Head-to-head evidence: Furosemide (subcutaneous, scPharmaceuticals) vs Furosemide (subcutaneous, SQ Innovation) · Furosemide (subcutaneous, SQ Innovation) vs Torsemide (Soaanz) · Furosemide (subcutaneous, scPharmaceuticals) vs Torsemide (Soaanz)